Immune-Boosting Adjuvants
2007; Mary Ann Liebert, Inc.; Volume: 5; Issue: 3 Linguagem: Estoniano
10.1089/bsp.2007.0033
ISSN1557-850X
AutoresAllison T. Chamberlain, Gigi Kwik Grönvall,
Tópico(s)Hepatitis B Virus Studies
ResumoBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and ScienceVol. 5, No. 3 Science for PolicymakersImmune-Boosting AdjuvantsAllison Chamberlain and Gigi Kwik GronvallAllison ChamberlainSearch for more papers by this author and Gigi Kwik GronvallSearch for more papers by this authorPublished Online:28 Sep 2007https://doi.org/10.1089/bsp.2007.0033AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byConfronting the threat of bioterrorism: realities, challenges, and defensive strategiesThe Lancet Infectious Diseases, Vol. 19, No. 1 Volume 5Issue 3Sep 2007 InformationMary Ann Liebert, Inc.To cite this article:Allison Chamberlain and Gigi Kwik Gronvall.Immune-Boosting Adjuvants.Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science.Sep 2007.202-205.http://doi.org/10.1089/bsp.2007.0033Published in Volume: 5 Issue 3: September 28, 2007PDF download
Referência(s)